BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Biotech Beach

  Endologix, Inc. Completes Patient Enrollment in the ELEVATE IDE Clinical Study

  Endologix announced today the completion of enrollment in the Expanding Patient Applicability with Polymer Sealing Ovation Alto Stent Graft (ELEVATE) IDE clinical study.

  February 5, 2018

   · 

  4 min read
• Business

  Sensus Healthcare Launches Collaboration with BirchBioMed to Treat and Prevent Scarring for Keloids Patients Around the World

  Sensus’ SRT delivers precise, calibrated low-dose radiation that effectively destroys the non-malignant tumor cells that cause keloids and other scars.

  February 5, 2018

   · 

  3 min read
• Business

  NanoSphere Health Sciences Increases Capacity at Key Colorado Production Facility

  Nanosphere is pleased to announce that, in response to growing demand for the NanoSphere’s Evolve NanoSerum product, its Colorado license partner has increased production capacity at its facility.

  February 5, 2018

   · 

  4 min read
• Pharm Country

  Novo Nordisk Launches Ozempic and Fiasp, Expanding Treatment Options for Adults With Diabetes

  Novo Nordisk today announced the availability of two new diabetes medications, Ozempic injection 0.5 mg or 1 mg and Fiasp 100 Units/mL at pharmacies across the United States.

  February 5, 2018

   · 

  11 min read
• Lone Star Bio

  Vermillion Announces the Grant of Two Ovarian Cancer Diagnostic Patents

  Vermillion announced today that it has been granted two new US patents that significantly expand coverage for its core technologies, OVA1 and Overa.

  February 5, 2018

   · 

  1 min read
• Invictus Receives $16.5M From Warrants and Option Exercises Since Dec 22, 2017 and Increases Funded Capacity in 2018 to 27,200 Kg

  Invictus Medical is pleased to announce that it has received an additional $16,536,234 from the exercise of previously issued warrants and options since December 22, 2017, bringing Invictus’ cash balance to approximately $38M.

  February 5, 2018

   · 

  10 min read
• Biotech Beach

  EBD Group: BIO-Europe Spring(R) Returns to Amsterdam for High-Level Partnering Among Innovative Biotech, Pharma and Investors

  The twelfth annual BIO-Europe Spring(R) international partnering conference returns to Amsterdam, The Netherlands, March 12-14, 2018 at the Amsterdam RAI Convention Center.

  February 5, 2018

   · 

  3 min read
• Health AI Startup Medial EarlySign Predicts Which Diabetic Patients Will Suffer Kidney Damage Within One Year

  This represents 25% more patients than would have been identified by commonly used clinical tools and judgement.

  February 5, 2018

   · 

  4 min read
• Business

  Acer Therapeutics Expands Management Team with the Appointment of Three Executives and One New Key Hire

  The new hires support Acer’s progression from development to potential commercialization of EDSIVO.

  February 5, 2018

   · 

  8 min read
• BioCapital

  CEL-SCI to Present at 2018 BIO CEO & Investor Conference

  CEL-SCI announced that Geert Kersten, Chief Executive Officer, will be presenting at the 2018 BIO CEO & Investor Conference on Tuesday, February 13, 2018 at 9:45 a.m.

  February 5, 2018

   · 

  1 min read